NGeneBio Co., Ltd. (KOSDAQ:354200)
South Korea
· Delayed Price · Currency is KRW 1,954.00
-81.00 (-3.98%)
At close: Mar 9, 2026
NGeneBio Market Cap
NGeneBio has a market cap or net worth of 50.59 billion as of March 10, 2026. Its market cap has increased by 47.11% in one year.
Market Cap
50.59B
Enterprise Value
60.87B
Revenue
9.98B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,954.00
Market Cap Chart
Since December 10, 2020, NGeneBio's market cap has decreased from 313.33B to 50.59B, a decrease of -83.86%. That is a compound annual growth rate of -29.35%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptamer Sciences | 57.45B |
| EyeGene | 60.09B |
| J2KBIO | 45.32B |
| SunBio,Inc. | 64.75B |
| HLB Pep | 64.87B |
| PanGen Biotech | 66.86B |
| Ark Solutions | 68.91B |
| CHA Vaccine Research Institute | 72.80B |